Contact us

Support


Home > Investment tools > They choose Russia > Macleods Pharmaceuticals Ltd

Macleods Pharmaceuticals Ltd

India-based drugmaker, Macleods Pharmaceuticals, has announced an investment of $25 million in the construction of a plant for the production of anti-tuberculous drugs in Russia’s Belgorod region by 2016.

Sergey Mironov, Head of Advanced Trading, stated that the new plant will focus on the production of life-saving medicines, which are expected to be in high demand in the Russian market. At the initial stage the new plant will focus on the production of anti-tuberculosis medicines, while later the production range is expected to be expanded.

The new plant will create more than 160 new jobs at the initial stage. 

21 December 2012
Investor
2016
25.0 mln
Jobs: 160
Belgorod region

Investor profile

Macleods Pharmaceuticals Ltd

Mumbai, India

T: +91 2266762800

Contact: Mr Sergey Mironov, Head of Advanced Trading, Russia

Macleods Pharmaceuticals is a vertically integrated drug company, founded in 1986. The company has anti-tuberculosis as a focused area of operation and supplies first line and second line anti-tuberculosis drugs.

Subscribe to Newsletters

Email: